Full Text View
Tabular View
No Study Results Posted
Related Studies
Vascular Endothelial Growth Factor(VEGF)Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) (VIEW 1)
This study is ongoing, but not recruiting participants.
Study NCT00509795   Information provided by Regeneron Pharmaceuticals
First Received: July 31, 2007   Last Updated: September 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
VEGF Trap-Eye
Ranibizumab
Additional drug interventions recognized in this trial
Endothelial Growth Factors
More general drug interventions related to this trial
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Regeneron Pharmaceuticals
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services